The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABD.L Regulatory News (ABD)

  • There is currently no data for ABD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Combination with Asia Dragon Trust plc

21 Jul 2023 07:00

RNS Number : 7233G
abrdn New Dawn Invest Trust plc
21 July 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, IN ANY MEMBER STATE OF THE EEA OR IN ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL

This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in the United States or in any other jurisdiction in which the same would be unlawful. Neither this announcement nor any part of it shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

 

21 July 2023

abrdn New Dawn Investment Trust plc

 

Legal Entity Identifier: 5493002K00AHWEME3J36

 

Proposed combination with Asia Dragon Trust plc

 

 

Introduction

 

The Board of abrdn New Dawn Investment Trust plc ("abrdn New Dawn" or the "Company") is pleased to announce that it has agreed heads of terms with the Board of Asia Dragon Trust plc ("Asia Dragon") in respect of a proposed combination of abrdn New Dawn with Asia Dragon. The combination, if approved by each company's shareholders, will be effected by way of a scheme of reconstruction and winding up of abrdn New Dawn under section 110 of the Insolvency Act 1986 and the associated transfer of part of the assets and undertaking of abrdn New Dawn to Asia Dragon in exchange for the issue of new ordinary shares in Asia Dragon ("New Asia Dragon Shares") (the "Scheme"). Under the terms of the Scheme an up to 25 per cent. cash exit opportunity will be offered to abrdn New Dawn shareholders to realise part of their investment in the Company.

 

The current investment manager of both companies, abrdn Fund Managers Limited ("AFML"), will, following implementation of the Scheme, continue to manage the enlarged Asia Dragon. The Asia Dragon board will propose certain amendments to Asia Dragon's investment policy to its shareholders (the "Investment Policy Change") which will principally align Asia Dragon's policy with the Company's current investment policy in order to permit investment into Australasia and provide the management team with equivalent geographic flexibility. Asia Dragon's existing benchmark comparative index (MSCI AC Asia (ex-Japan) Index) will be retained. The portfolio managers of the enlarged Asia Dragon will be Pruksa Iamthongthong and James Thom.

 

The Scheme and the Investment Policy Change are together referred to as the "Proposals".

 

The Board of abrdn New Dawn believes that, if the Proposals are implemented, abrdn New Dawn shareholders rolling over into Asia Dragon will benefit from, amongst other things, the greater economies of scale that are expected to result from the enlarged asset base, including greater secondary liquidity in Asia Dragon shares and cost efficiencies.

 

abrdn New Dawn and Asia Dragon have received irrevocable undertakings to support the Proposals from shareholders representing 27.0 per cent. of abrdn New Dawn's issued share capital and 29.7 per cent. of Asia Dragon's issued share capital (as at 20 July 2023).

 

 

Summary of the Scheme

 

The Proposals will be effected by way of a scheme of reconstruction of abrdn New Dawn under section 110 of the Insolvency Act 1986, resulting in the voluntary winding up of abrdn New Dawn and the transfer of part of abrdn New Dawn's assets to Asia Dragon on a Formula Asset Value ("FAV") for FAV basis. In accordance with customary practice for such transactions involving investment trusts, the City Code on Takeovers and Mergers is not expected to apply to the Proposals. However, the Proposals will be subject to other regulatory and tax approvals. The Proposals will also be subject to, inter alia, approval by the shareholders of each of abrdn New Dawn and Asia Dragon. 

 

Under the Scheme, abrdn New Dawn's shareholders will be entitled to elect to receive in respect of some or all of their abrdn New Dawn shares:

· New Asia Dragon Shares (the "Rollover Option"); and/or

· cash (the "Cash Option").

 

The Cash Option is limited to 25 per cent. of abrdn New Dawn's shares in issue (excluding treasury shares). Should total elections for the Cash Option exceed 25 per cent. of abrdn New Dawn's shares in issue (excluding treasury shares), excess elections for the Cash Option will be scaled back into New Asia Dragon Shares on a pro rata basis.

 

The Cash Option will be offered at a discount of 2 per cent. to the abrdn New Dawn FAV (the "Cash Discount") less the costs of realising the assets allocated to the cash pool for the benefit of the shareholders electing for the Cash Option. The Cash Discount will be for the benefit of the enlarged Asia Dragon.

 

New Asia Dragon Shares will be issued as the default option under the Scheme in the event that abrdn New Dawn shareholders do not make a valid election under the Scheme or to the extent elections for the Cash Option are scaled back as a result of the Cash Option being oversubscribed.

 

 

Rationale and Benefits of the Scheme

 

abrdn New Dawn and Asia Dragon both invest in the Asia Pacific (ex-Japan) region and both are managed by AFML with a high level of commonality across their shareholder bases. In light of these similarities, the Boards believe a combination of the companies will create an enlarged vehicle that offers similar investment exposure for each set of shareholders while offering shareholders in the enlarged Asia Dragon the following benefits:

 

· Enhanced profile: The enlarged Asia Dragon is expected to have net assets in excess of £700 million (as at 20 July 2023), creating a leading closed-ended vehicle for investment in the Asia Pacific (ex-Japan) region managed by abrdn. On the basis of the current market capitalisations of abrdn New Dawn and Asia Dragon, the enlarged Asia Dragon would be expected to qualify for inclusion in the FTSE 250 raising the profile and enhancing the marketability of the enlarged Asia Dragon.

 

· Lower tiered management fee: AFML has agreed that, with effect from the admission to listing and trading of the New Asia Dragon Shares ("Admission"), the management fee payable by Asia Dragon to AFML will be reduced to 0.75 per cent. (currently 0.85 per cent.) on the initial £350 million of Asia Dragon's net assets and 0.5 per cent. on Asia Dragon's net assets in excess of £350 million. In addition, the enlarged Asia Dragon will benefit from lower costs following implementation of the Proposals as Asia Dragon's tiered fee structure will have the effect of reducing the weighted average fee given the increase in Asia Dragon's net assets.

 

· Lower ongoing charges: Existing and new shareholders in Asia Dragon are expected to benefit from a lower ongoing expense ratio with the enlarged Asia Dragon's fixed costs spread over a larger asset base.

 

· Enhanced liquidity: The scale of the enlarged company is expected to improve the secondary market liquidity of Asia Dragon's shares.

 

· Shareholder register: The Proposals will allow a number of shareholders to consolidate their holdings across the two companies while also creating a more diversified shareholder base through a combination of the balance of the two share registers.

 

· Contribution to costs: As described below, AFML has agreed to make a cost contribution in respect of the Proposals which, in addition to the contribution to the costs from the Cash Discount described above, is expected to offset the direct transaction costs for Asia Dragon shareholders.

 

· Conditional tender offer: Asia Dragon offers a five-yearly performance related conditional tender ("Conditional Tender") with the current performance period running from 1 September 2021 to 31 August 2026 ("2026 CTO"). It is proposed that, in the light of the Proposals and conditional on the Scheme being implemented, the 2026 CTO will be amended such that, in the event Asia Dragon underperforms the Benchmark over the performance period, Asia Dragon will offer shareholders the opportunity to tender up to a maximum of 15 per cent. of their shares; a reduction from the maximum of 25 per cent. previously proposed. This reflects the revised Conditional Tender being of broadly a similar size to that previously proposed for the 2026 CTO, given the greater scale of the enlarged Asia Dragon. 

 

· Continuation Vote: Asia Dragon shareholders will have the opportunity to vote on the continuation of Asia Dragon at every fifth AGM ("Continuation Vote") with the next Continuation Vote to be put forward at the AGM in December 2026.

 

 

Costs of the Proposals and AFML Contribution

 

Each company intends to bear its own costs incurred in relation to the Proposals and the direct costs will be reflected in the FAV for each company.

 

AFML has agreed to make a contribution to the costs of the Scheme by means of a reduction in the management fee payable by Asia Dragon to AFML. The fee reduction will constitute a waiver of the management fee that would otherwise be payable to AFML in respect of the assets transferred by abrdn New Dawn to Asia Dragon pursuant to the Scheme for the first six months following the completion of the Scheme (the "AFML Contribution"). The AFML Contribution will be for the benefit of the shareholders of the enlarged Asia Dragon following implementation of the Scheme.

 

 

Debt Facilities

 

It is expected that abrdn New Dawn's existing fixed rate and revolving credit facilities, which are currently drawn at £28.55 million (as at 20 July 2023), will be repaid and closed prior to the implementation of the Scheme.

 

 

Change of Asia Dragon Investment Policy

 

It is intended that Asia Dragon will seek shareholder approval for the Investment Policy Change at the general meeting to be held by Asia Dragon in connection with the Proposals. The proposed amendments to the Asia Dragon investment policy will, inter alia, allow for investment in Australasia in order to provide the management team greater geographic flexibility, already reflected in abrdn New Dawn's current investment policy. Asia Dragon's existing benchmark comparative index (MSCI AC Asia (ex-Japan) Index) will be retained.

 

 

Board Structure

 

Following completion of the Proposals, it is expected that the Board of the enlarged Asia Dragon will consist of eight directors and will include the five existing Asia Dragon directors and three of the existing abrdn New Dawn directors. After a transition period that will end on the six month anniversary of Admission, it is intended that the Board of the enlarged Asia Dragon will reduce to five directors consisting of three existing Asia Dragon directors and two existing abrdn New Dawn directors.

 

 

Annual Financial Statements and Second Interim Dividend

 

In light of the Proposals, the Company's annual financial report for the year ended 30 April 2023 will be published in August 2023. A second interim dividend for the year then ended is expected to be declared at the end of July 2023.

 

 

Expected Timetable

 

A circular to shareholders of the Company, providing further details of the Scheme and convening general meetings to approve the Scheme, together with a prospectus published by Asia Dragon in respect of the issue of New Asia Dragon Shares in connection with the Scheme are expected to be published in September 2023. The Proposals are anticipated to become effective in October 2023. 

 

 

The Chairman of abrdn New Dawn, Donald Workman, commented:

 

"The combination of abrdn New Dawn Investment Trust plc with Asia Dragon Trust plc will provide additional scale and liquidity for continuing shareholders, whilst broadly retaining abrdn New Dawn's existing investment policy. Both companies already benefit from a similar investment approach and management style within the same investment group. This additional scale and Asia Dragon's tiered fee structure, combined with the reduced fee arrangements, will also result in a lower ongoing charges ratio for continuing shareholders. As part of the transaction abrdn New Dawn shareholders will be offered the opportunity to benefit from a partial realisation of their holding at a small discount to the formula asset value. The enlarged scale should also make Asia Dragon more attractive for potential new investors over time."

 

 

 

For further information please contact:

 

abrdn New Dawn Investment Trust plc

Donald Workman

 

Contact via AFML

abrdn Fund Managers Limited

Maria Allen

Luke Mason

Stephanie Hocking

 

 

 

+44 (0) 20 3680 0305

+44 (0) 20 7463 5971

+44 (0) 7514 064 988

Panmure Gordon (UK) Limited

Alex Collins

Sapna Shah

Ashwin Kohli

 

 

+44 (0) 20 7886 2500

+44 (0) 20 7886 2783

+44 (0) 20 7886 2786

 

Important Information

 

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation). abrdn Holdings Limited, Company Secretary to abrdn New Dawn Investment Trust plc has arranged the release of this announcement. 

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFSIDIIIFIV
Date   Source Headline
6th Nov 20235:14 pmRNSMonth End Net Asset Value(s)
6th Nov 202310:15 amRNSResult of Elections
3rd Nov 202312:39 pmRNSNet Asset Value(s)
2nd Nov 20232:22 pmRNSQuarterly disclosure
2nd Nov 202311:54 amRNSNet Asset Value(s)
2nd Nov 20237:30 amRNSSuspension - abrdn New Dawn Investment Trust plc
1st Nov 202310:05 amRNSTotal Voting Rights
31st Oct 202312:50 pmRNSNet Asset Value(s)
30th Oct 202312:12 pmRNSNet Asset Value(s)
27th Oct 202312:19 pmRNSNet Asset Value(s)
26th Oct 202312:56 pmRNSNet Asset Value(s)
25th Oct 20236:00 pmRNSABRDN New Dawn Investment Trust
25th Oct 202312:36 pmRNSNet Asset Value(s)
24th Oct 202312:30 pmRNSNet Asset Value(s)
23rd Oct 20233:57 pmRNSResults of GM and AGM
23rd Oct 202312:53 pmRNSGearing disclosure
23rd Oct 202311:19 amRNSNet Asset Value(s)
20th Oct 202312:04 pmRNSNet Asset Value(s)
19th Oct 202312:09 pmRNSNet Asset Value(s)
18th Oct 20233:46 pmRNSPre-liquidation Dividend
18th Oct 202312:06 pmRNSNet Asset Value(s)
17th Oct 202311:14 amRNSNet Asset Value(s)
16th Oct 20232:41 pmRNSGearing disclosure
16th Oct 20231:21 pmRNSNet Asset Value(s)
13th Oct 20235:26 pmRNSPortfolio disclosure
13th Oct 20235:18 pmRNSTransaction in Own Shares
13th Oct 202311:53 amRNSNet Asset Value(s)
13th Oct 202310:51 amRNSCancellation of Treasury Shares
12th Oct 202311:48 amRNSNet Asset Value(s)
11th Oct 202311:41 amRNSNet Asset Value(s)
10th Oct 20235:53 pmRNSTransaction in Own Shares
10th Oct 202312:53 pmRNSNet Asset Value(s)
9th Oct 20232:33 pmRNSGearing disclosure
9th Oct 20231:30 pmRNSNet Asset Value(s)
6th Oct 20235:19 pmRNSTransaction in Own Shares
6th Oct 202312:34 pmRNSNet Asset Value(s)
5th Oct 20234:20 pmRNSHolding(s) in Company
5th Oct 20233:23 pmRNSMonth End Net Asset Value(s)
5th Oct 202312:55 pmRNSNet Asset Value(s)
4th Oct 202312:59 pmRNSNet Asset Value(s)
4th Oct 202311:24 amRNSGearing disclosure
3rd Oct 202312:43 pmRNSNet Asset Value(s)
2nd Oct 202310:57 amRNSTotal Voting Rights
28th Sep 20231:13 pmRNSNet Asset Value(s)
27th Sep 20235:13 pmRNSHolding(s) in Company
27th Sep 202312:10 pmRNSNet Asset Value(s)
26th Sep 202312:24 pmRNSNet Asset Value(s)
25th Sep 20232:51 pmRNSGearing disclosure
25th Sep 202312:46 pmRNSNet Asset Value(s)
22nd Sep 20232:00 pmRNSPublication of Circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.